Fierce Biotech

AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta

AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. | The ...
Fierce Pharma

AZ looks to grow reach in lupus with phase 3 win for self-administered Saphnelo

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...
fox6now

New study vindicates UK's delay of 2nd AstraZeneca vaccine dose

LONDON (AP) - Britain’s health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it ...

AstraZeneca’s DAHLIA Lupus Study: Real‑World Data Could Strengthen Anifrolumab’s Long‑Term Investment Case

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Pharmabiz

AstraZeneca announces Saphnelo self-administration phase III TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity

AstraZeneca announces Saphnelo self-administration phase III TULIP-SC trial demonstrates statistically significant and clinically meaningful reduction in SLE disease activity: Cam ...
Naija Gist - Latest

Coronavirus: Nigerians awaiting second dose of AstraZeneca vaccine to heave sigh of relief soon

Nigerians awaiting their second dose of the Oxford/AstraZeneca vaccine can sigh of relief as the government on 17 August 2021 received additional 699,760 doses in Abuja. Receiving the vaccines at the ...